BNET Industries

Pfizer Inc.

(PFE) is in the Pharma Industry

Market Cap:$147.2B
Last Fiscal Year Sales:$48.4B
  • Public
  • US
Dow Jones Description

Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.

Number of Employees 81,800
Contact Information

235 E 42nd St

New York, New York 10017-5755

www.pfizer.com

(212) 573-2323

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • Can Roche Leave Genentech Alone?

    11/25/09 - Merger / Acquisition - View Story

  • Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV

    11/24/09 - Joint Venture / Alliance - View Story

  • Pfizer Inc. and Wyeth; Analysis of Agreement Containing Consent Order To Aid Public Comment and...

    11/27/09 - Financial Announcement - View Story

  • A 2nd Loss for Pfizer in Drug Suits

    11/23/09 - Legal Settlement - View Story

  • Pfizer acquires stem cell therapies assets of Axordia

    11/23/09 - Merger / Acquisition - View Story

  • Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24

    11/23/09 - Bond / Stock Rating - View Story

  • ImmunoVaccine signs exclusive licence deal with Pfizer

    11/23/09 - Joint Venture / Alliance - View Story

  • Pfizer Animal Health selects Bader Rutter as agency of record

    11/17/09 - Licensing / Contract - View Story

  • FDA panel backs Pfizer's anti-infection vaccine for kids

    11/19/09 - Merger / Acquisition - View Story

  • Cash Just Kept On Piling Up, But It Looks Like The Spending Has Started

    11/16/09 - Joint Venture / Alliance - View Story

  • Goldman Sachs Said Pfizer PFE Best Positioned US Pharma in China

    11/16/09 - Bond / Stock Rating - View Story

  • EDITORIAL: Difficult mix of business, science

    11/24/09 - Merger / Acquisition - View Story

  • $75M verdict unsealed in Prempro-cancer case

    11/27/09 - Merger / Acquisition - View Story

  • Sanofi-Aventis on hunt for Boston partners

    11/11/09 - Merger / Acquisition - View Story

  • Pfizer says in partnership deal with BMP in China

    11/10/09 - Joint Venture / Alliance - View Story

  • Pfizer Inc. PFE Says in Partnership Deal with BMP Sunstone in China

    11/10/09 - Joint Venture / Alliance - View Story

  • Still Enjoying Those Acquisitions, Pfizer?

    11/25/09 - Merger / Acquisition - View Story

  • Status Of Pfizer And Wyeth Research Facilities

    11/09/09 - Merger / Acquisition - View Story

  • Monsanto MON Agrees to Acquire Pfizer's PFE Chesterfield Village Research Center for $435M

    11/09/09 - Merger / Acquisition - View Story

News & Analysis

healthcare and pfizer inc. - All News and Analysis

  • Pfizer's Cutbacks Reflect Difficulties Facing Big Pharma

    Seeking Alpha - 2009-11-10

    ChinaBio Today submits: Pfizer (NYSE: PFE) announced it would close six out of its 20 R&D facilities around the globe as part of its post-Wyeth-acquisition consolidation. Some employees will be transferred to other facilities, while others will be let go. Pfizer did not disclose how many of its R&D...

    Tags: Healthcare, China, ChinaBio Today, Pfizer Inc.

  • Pfizer Q3: Earnings Beat, But Revenue Down

    Seeking Alpha - 2009-10-20

    Zacks.com submits: Pfizer Inc. PFE reported third quarter net income of 51 cents per share, which beat the Zacks Consensus Estimate of 48 cents. The company’s net income was 62 cents per share in the year-ago quarter. Revenues for the quarter decreased 3% to $11.6 billion. Revenues for...

    Tags: Healthcare, Zacks.com, Pfizer Inc.

  • Pfizer: What It Will Look Like a Year from Now

    Seeking Alpha - 2009-10-20

    Derek Lowe submits: The Wall Street Journal's Health Blog got a chance to ask the higher-ups at Pfizer PFE what their R&D will look like a year from now. Their understandably not too-in-depth answers are here: Decentralized research units, with some functions run company-wide, and this quote: "There are...

    Tags: Healthcare, Derek Lowe, Pfizer Inc.

  • Earnings Preview: Pfizer

    Seeking Alpha - 2009-10-19

    Pfizer PFE is expected to report Q3 earnings Tuesday, October 20 before market open, with a conference call scheduled for 10am ET. Guidance Analysts are looking for EPS of 48c on revenue of $11.42B. The consensus range is 47c-50c for EPS, and $11.06B-$11.66B for revenue, according to First Call....

    Tags: Healthcare, theflyonthewall.com, Pfizer Inc.

  • Pfizer Wastes No Time Realizing Cost Efficiencies

    Seeking Alpha - 2009-10-16

    Ockham Research submits: The largest deal among drug makers in the last year was completed today as Pfizer PFE officially merged with Wyeth WYE. At the close of trading on Thursday, Wyeth was delisted from the NYSE. Pfizer has wasted no time in announcing some of its...

    Tags: Healthcare, Ockham Research, Pfizer Inc.

advertisement
     PFE $18.25 -0.34 (-1.83% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 52,180,000
Shares Outstanding 8.07B
Market Cap 147.3B
Year High 18.9
Year Low 11.68
Earnings Per Share 1.20
P/E Ratio 15.21
Dividend 0.64
Yield 3.51
IndustryTop Rated
advertisement
Click Here